Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002410 Glodon
- 14.49
- 0.000.00%
Not Open Apr 1 15:00 CST
23.94BMarket Cap95.33P/E (TTM)
14.77High14.32Low348.85KlotVolume14.44Open14.49Pre Close507.47MTurnover2.20%Turnover Ratio95.33P/E (Static)1.65BShares16.2552wk High4.02P/B23.01BFloat Cap8.3552wk Low15.94Limit Up1.59BShs Float65.43Historical High13.04Limit Down3.11%Amplitude0.96Historical Low0.07Dividend TTM14.55Avg Price168.66KlotAsk0.48%Div YieldTTM100Lot Size164.07KlotBid
Glodon Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -9.65%6.29B | -10.51%3.86B | -8.83%2.19B | -15.14%660.95M | -2.61%6.96B | -1.80%4.31B | -2.81%2.41B | 19.91%778.91M | 12.56%7.15B | 11.94%4.39B |
| Refunds of taxes and levies | 30.16%53.87M | 73.58%49.06M | 88.51%43.78M | -38.58%5.82M | -39.30%41.39M | -48.86%28.26M | -46.74%23.22M | 11.73%9.48M | 3.26%68.18M | 18.74%55.26M |
| Cash received from interests, fees and commissions | -17.16%34.42M | -17.83%27.69M | 6.97%21.64M | 20.96%16.14M | 28.03%41.55M | 80.24%33.7M | 88.26%20.23M | 73.21%13.34M | -43.22%32.46M | -58.50%18.7M |
| Cash received relating to other operating activities | -39.94%118.09M | -65.11%69.51M | -74.62%46.52M | -74.01%42.73M | 25.19%196.63M | 68.61%199.2M | 85.21%183.31M | 556.82%164.4M | -13.04%157.07M | -23.13%118.14M |
| Cash inflows from operating activities | -10.29%6.49B | -12.42%4B | -12.43%2.31B | -24.89%725.64M | -2.23%7.24B | -0.22%4.57B | 0.15%2.63B | 39.86%966.13M | 11.30%7.4B | 9.96%4.58B |
| Goods services cash paid | -33.87%640.03M | -21.94%490.69M | -7.98%370.15M | 23.31%220.99M | 19.27%967.9M | 36.61%628.56M | 35.62%402.25M | 27.10%179.22M | -0.48%811.53M | 3.40%460.12M |
| Staff behalf paid | -7.36%3.68B | -3.36%2.91B | -1.27%2.09B | -15.63%974.98M | 12.61%3.97B | 11.62%3.01B | 14.77%2.11B | 60.40%1.16B | 28.11%3.53B | 24.18%2.7B |
| All taxes paid | -4.93%425.85M | -9.09%300.87M | -11.69%179.04M | -51.27%54.74M | 3.31%447.92M | 3.91%330.97M | 13.85%202.73M | 55.14%112.33M | 11.73%433.59M | 21.29%318.5M |
| Net loan and advance increase | -215.50%-196.07M | -137.86%-82.38M | -62.33%56.8M | -42.41%101.86M | 1,141.13%169.76M | 574.19%217.59M | 325.80%150.77M | 381.41%176.87M | -87.09%13.68M | -133.26%-45.89M |
| Cash paid relating to other operating activities | -28.11%751.45M | -35.31%518.58M | -37.45%297.51M | -53.80%123.14M | 7.66%1.05B | -0.46%801.6M | 3.73%475.66M | 30.82%266.55M | -1.79%970.95M | 19.82%805.28M |
| Cash outflows from operating activities | -19.72%5.3B | -17.09%4.14B | -10.60%2.99B | -21.94%1.48B | 14.70%6.6B | 17.81%4.99B | 23.52%3.34B | 75.90%1.89B | 13.96%5.76B | 14.79%4.23B |
| Net cash flows from operating activities | 87.41%1.19B | 68.23%-132.48M | 3.86%-683.41M | 18.86%-750.07M | -61.34%636.96M | -220.12%-416.96M | -813.56%-710.84M | -140.75%-924.43M | 2.89%1.65B | -27.33%347.12M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 74.66%3.28B | 39.29%1.71B | -28.79%734.56M | -40.96%259.78M | 17.39%1.88B | 140.73%1.22B | 243.40%1.03B | 46.49%440M | 5,450.40%1.6B | 2,704.54%508.51M |
| Cash received from returns on investments | -37.74%16.66M | 17.00%11.33M | -15.50%6.89M | -50.99%2.25M | 103.18%26.76M | -46.91%9.68M | -47.72%8.16M | 93.51%4.58M | -14.74%13.17M | 83.94%18.24M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 35.18%2.72M | 9.59%1.75M | 310.83%1.53M | 2,658.53%1.13M | 337.34%2.01M | 464.14%1.6M | 148.69%373.22K | --40.91K | 9.65%460.29K | -70.98%283.27K |
| Net cash received from disposal of subsidiaries and other business units | 78.01%6.71M | 78.01%6.71M | --6.71M | ---- | --3.77M | --3.77M | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -83.90%17.6M | -82.01%17.6M |
| Cash inflows from investing activities | 73.05%3.3B | 39.19%1.72B | -27.92%749.7M | -40.82%263.15M | 17.13%1.91B | 127.53%1.24B | 228.99%1.04B | 46.87%444.62M | 958.37%1.63B | 329.33%544.63M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -28.44%437.27M | -27.59%355.42M | -45.17%210.99M | -51.56%109.84M | -28.07%611.08M | -24.82%490.85M | -11.81%384.79M | 44.34%226.74M | 17.92%849.51M | 56.43%652.87M |
| Cash paid to acquire investments | 72.40%3.21B | 55.16%2.13B | -35.98%764.51M | 5.82%703.68M | 9.03%1.86B | 16.67%1.37B | 196.31%1.19B | 352.07%665M | 75.05%1.71B | 28.51%1.17B |
| Net cash paid to acquire subsidiaries and other business units | -89.59%11M | -84.98%11M | ---- | ---- | 193.95%105.69M | 143.61%73.23M | --74.87M | --72.69M | --35.95M | --30.06M |
| Cash paid relating to other investing activities | 103.91%537.81K | 46.85%394.42K | 109.29%278.42K | --130.7K | -86.91%263.75K | -82.71%268.58K | -82.56%133.03K | ---- | --2.01M | --1.55M |
| Cash outflows from investing activities | 41.85%3.66B | 28.86%2.49B | -41.00%975.78M | -15.63%813.65M | -0.63%2.58B | 4.07%1.93B | 96.88%1.65B | 216.41%964.42M | 53.01%2.59B | 39.64%1.86B |
| Net cash flows from investing activities | 47.23%-352.84M | -10.45%-768.21M | 63.17%-226.08M | -5.91%-550.5M | 30.66%-668.59M | 47.08%-695.55M | -17.16%-613.82M | -25,124.77%-519.8M | 37.44%-964.23M | -9.13%-1.31B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | -15.26%250.09M | -93.93%17.92M | -77.01%17.92M | -75.50%17.92M | -53.62%295.14M | -30.06%295.14M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | --13.2M | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | --8.23M | --1.04M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | --93.64M | --93.64M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -59.27%101.87M | 428.48%94.68M | ---- | ---- | -15.26%250.09M | -93.93%17.92M | -77.01%17.92M | -75.50%17.92M | -53.77%295.14M | -30.39%295.14M |
| Dividend interest payment | -70.93%140.1M | -70.58%138.38M | -74.38%120.49M | 0.70%645.49K | 17.45%481.87M | 14.86%470.38M | 17.12%470.38M | -97.68%641.03K | 15.91%410.29M | 21.58%409.54M |
| -Including:Cash payments for dividends or profit to minority shareholders | 118.28%22.14M | --20.97M | --3.53M | ---- | -82.51%10.14M | ---- | ---- | ---- | -9.47%57.98M | 43.36%57.98M |
| Cash payments relating to other financing activities | 51.14%586.8M | 168.09%277.26M | 913.72%272.1M | 568.69%36.78M | 49.79%388.24M | -56.12%103.42M | -88.14%26.84M | -97.46%5.5M | -76.41%259.19M | -56.75%235.7M |
| Cash outflows from financing activities | -16.46%726.9M | -27.56%415.64M | -21.04%392.58M | 509.40%37.42M | 29.97%870.11M | -11.07%573.8M | -20.81%497.22M | -97.48%6.14M | -54.08%669.48M | -27.24%645.24M |
| Net cash flows from financing activities | -0.81%-625.03M | 42.26%-320.96M | 18.09%-392.58M | -417.82%-37.42M | -65.63%-620.02M | -58.78%-555.89M | 12.84%-479.31M | 106.89%11.78M | 54.32%-374.34M | 24.36%-350.1M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -28.02%5.45M | -88.46%393.36K | -91.98%1.02M | 81.35%-865.67K | -67.29%7.58M | -85.87%3.41M | 40.92%12.7M | 24.11%-4.64M | 281.26%23.17M | 321.24%24.11M |
| Net increase in cash and cash equivalents | 134.36%221.3M | 26.65%-1.22B | 27.37%-1.3B | 6.84%-1.34B | -293.89%-644.08M | -28.74%-1.66B | -56.77%-1.79B | -155.26%-1.44B | 143.01%332.19M | -7.72%-1.29B |
| Add:Begin period cash and cash equivalents | -14.94%3.67B | -14.94%3.67B | -14.94%3.67B | -14.94%3.67B | 8.35%4.31B | 8.35%4.31B | 8.35%4.31B | 8.35%4.31B | -16.25%3.98B | -16.25%3.98B |
| End period cash equivalent | 6.03%3.89B | -7.57%2.45B | -6.10%2.37B | -18.99%2.33B | -14.94%3.67B | -1.47%2.65B | -11.15%2.52B | -15.86%2.87B | 8.35%4.31B | -24.36%2.69B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.